These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1428 related articles for article (PubMed ID: 35105664)

  • 1. Gut microbiome and health: mechanistic insights.
    de Vos WM; Tilg H; Van Hul M; Cani PD
    Gut; 2022 May; 71(5):1020-1032. PubMed ID: 35105664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
    Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
    Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics.
    Chen J; Thomsen M; Vitetta L
    J Cell Biochem; 2019 Mar; 120(3):2713-2720. PubMed ID: 30443932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding connections and roles of gut microbiome in cardiovascular diseases.
    Rajendiran E; Ramadass B; Ramprasath V
    Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
    Duparc T; Plovier H; Marrachelli VG; Van Hul M; Essaghir A; Ståhlman M; Matamoros S; Geurts L; Pardo-Tendero MM; Druart C; Delzenne NM; Demoulin JB; van der Merwe SW; van Pelt J; Bäckhed F; Monleon D; Everard A; Cani PD
    Gut; 2017 Apr; 66(4):620-632. PubMed ID: 27196572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
    Massey W; Brown JM
    Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Bile Acids in Metabolic Control.
    Molinaro A; Wahlström A; Marschall HU
    Trends Endocrinol Metab; 2018 Jan; 29(1):31-41. PubMed ID: 29195686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids.
    Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G
    mBio; 2014 Aug; 5(4):. PubMed ID: 25118238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease.
    Masse KE; Lu VB
    Front Endocrinol (Lausanne); 2023; 14():1169624. PubMed ID: 37560311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of the Gut Microbiota in Bile Acid Metabolism.
    Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Cardiovascular Disease.
    Witkowski M; Weeks TL; Hazen SL
    Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of microbial products in the development of colorectal cancer: a review.
    Fang Y; Yan C; Zhao Q; Xu J; Liu Z; Gao J; Zhu H; Dai Z; Wang D; Tang D
    Bioengineered; 2021 Dec; 12(1):720-735. PubMed ID: 33618627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
    Agus A; Clément K; Sokol H
    Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
    Sivaprakasam S; Prasad PD; Singh N
    Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications.
    Muralitharan RR; Jama HA; Xie L; Peh A; Snelson M; Marques FZ
    Hypertension; 2020 Dec; 76(6):1674-1687. PubMed ID: 33012206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interactions between the intestinal microbiota and the host.
    Hertli S; Zimmermann P
    Mol Microbiol; 2022 Jun; 117(6):1297-1307. PubMed ID: 35403275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
    Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
    Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Host energy regulation via SCFAs receptors, as dietary nutrition sensors, by gut microbiota].
    Kimura I
    Yakugaku Zasshi; 2014; 134(10):1037-42. PubMed ID: 25274213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.